Μαλαισία - Αγγλικά - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

kotra pharma (m) sdn. bhd. - magnesium hydroxide; aluminium hydroxide; polymethylsiloxane,activated/simethicone -

Ισραήλ - Αγγλικά - Ministry of Health

pharma shalom - aluminium hydroxide; magnesium hydroxide; simethicone - suspension - aluminium hydroxide 175 mg / 5 ml; magnesium hydroxide 200 mg / 5 ml; simethicone 25 mg / 5 ml - antacid, antiflatulent, relief of sensation of heatburn.

Ισραήλ - Αγγλικά - Ministry of Health

pharma shalom - aluminium hydroxide; magnesium hydroxide - suspension - aluminium hydroxide 175 mg / 5 ml; magnesium hydroxide 200 mg / 5 ml - ordinary salt combinations - antacid.

Μάλτα - Αγγλικά - Medicines Authority

sanofi malta limited - dimeticone; aluminium hydroxide; magnesium hydroxide - oral suspension - dimeticone 25 mg; aluminium hydroxide 114 mg; magnesium hydroxide 200 mg - drugs for acid related disorders

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

exela pharma sciences, llc - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) - magnesium sulfate heptahydrate 500 mg in 1 ml - magnesium sulfate injection, usp is suitable for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those observed in hypocalcemia. in such cases, the serum magnesium level is usually below the lower limit of normal (1.5 to 2.5 meq/l) and the serum calcium level is normal (4.3 to 5.3 meq/l) or elevated. in total parenteral nutrition (tpn), magnesium sulfate may be added to the nutrient admixture to correct or prevent hypomagnesemia which can arise during the course of therapy. magnesium sulfate injection is also indicated for the prevention and control of seizures in pre-eclampsia and eclampsia, respectively. parenteral administration of the drug is contraindicated in patients with heart block or myocardial damage.

Βέλγιο - Αγγλικά - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

opella healthcare belgium sa-nv - aluminium oxide 200 mg; magnesium hydroxide 400 mg - chewable tablet - 200 mg - 400 mg - magnesium hydroxide 400 mg; aluminium oxide 200 mg - combinations

Βέλγιο - Αγγλικά - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sanofi belgium sa-nv - aluminium oxide hydrated 400 mg - eq. aluminium oxide 200 mg; magnesium hydroxide 400 mg - chewable tablet - combinations

Κένυα - Αγγλικά - Pharmacy and Poisons Board

gennova biopharmaceuticals limited block 1, plot no: p-1 & p-2, itbt park, phase-ii, - dried aluminium hydroxide and magnesium… - buccal film - dried aluminium hydroxide 150mg magnesium… - alimentary tract and metabolism

Ζιμπάμπουε - Αγγλικά - Medicines Control Authority

varichem pharmaceuticals (pvt) ltd - aluminium hydroxide, magnesium hydroxide; simethicone - suspension - 400; 318.4; 50 mg/10ml

Ηνωμένο Βασίλειο - Αγγλικά - MHRA (Medicines & Healthcare Products Regulatory Agency)

sanofi consumer healthcare - magnesium hydroxide; aluminium hydroxide gel dried; simeticone - oral suspension - 39mg/1ml ; 44mg/1ml ; 5mg/1ml